Suchergebnisse - "rucaparib"

PubPharm (404)

31

Liposome Formulations for the Strategic Delivery of PARP1 Inhibitors : Development and Optimization

enthalten in: Nanomaterials (Basel, Switzerland) | 2023

von Conceição, C. | Moe, E. | Ribeiro, P. | +1

32

Method of the synthesis of selenium homolog of rucaparib

enthalten in: Chemistry of heterocyclic compounds | 2023

von Lapcinska, S. | Arsenyan, P.

33

Method of the synthesis of selenium homolog of rucaparib

enthalten in: Chemistry of heterocyclic compounds | 2023

von Lapcinska, S. | Arsenyan, P.

34

Method of the synthesis of selenium homolog of rucaparib

enthalten in: Chemistry of heterocyclic compounds | 2023

von Lapcinska, S. | Arsenyan, P.

35

Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC

enthalten in: Nature reviews. Urology | 2023

von Stone, L.

CommentOn: N Engl J Med. 2023 Feb 23;388(8):719-732. - PMID 36795891

36

The effect of PARP inhibitors in homologous recombination proficient ovarian cancer : meta-analysis

enthalten in: Journal of chemotherapy (Florence, Italy) | 2023

von Skelin, M. | Šarčević, D. | Lešin Gaćina, D. | +3

37

Novel breakthroughs in advanced prostate cancer management

enthalten in: Expert review of anticancer therapy | 2023

von Lilly, E. | Sarkis, J. | Mahmoud, O. | +3

38

Matching BRCA and prostate cancer in a public health system : Report of the Italian Society for Uro-Oncology (SIUrO) consensus project

enthalten in: Critical reviews in oncology/hematology | 2023

von Lapini, A. | Caffo, O. | Conti, G. | +9

39

Re : Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010

enthalten in: European urology | 2023

von Qi, F. | Xu, Z. | Zou, Q.

CommentOn: Eur Urol. 2023 Mar;83(3):200-209. - PMID 36243543

40

Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10

enthalten in: EBioMedicine | 2023

von Colomban, O. | Swisher, E. | Kristeleit, R. | +7